Microneedling RF + PLLA for Facial Rejuvenation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests microneedling with radiofrequency to determine if it improves facial appearance by altering fat thickness in areas like the temples, cheeks, and under the chin. Some participants will also use a topical treatment called PLLA, a type of dermal filler, to assess its impact on the results. The trial will measure participants' satisfaction with the treatment and their perceived outcomes. Those interested in this trial should have cosmetic concerns about their face and should not have had recent facial treatments or surgery. As an unphased trial, this study offers an opportunity to explore innovative cosmetic treatments and contribute to advancing aesthetic medicine.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using glucagon-like peptide-1 receptor agonists (like Ozempic or semaglutide) during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that microneedling with radiofrequency (RF) is generally safe and well-tolerated for various skin issues, especially when performed by trained professionals. However, serious risks include burns, scarring, fat loss, and nerve damage. Proper training and equipment are crucial to prevent these problems.
Using microneedling RF with poly-L-lactic acid (PLLA) can firm the skin without causing fat loss. This combination effectively tightens loose or sagging skin.
Overall, despite potential risks, microneedling RF and its combination with PLLA are generally safe when performed correctly. Treatments should be conducted by qualified professionals using approved devices to minimize the risk of complications.12345Why are researchers excited about this trial's treatments?
Researchers are excited about microneedling radiofrequency (RF) with topical poly-L-lactic acid (PLLA) for facial rejuvenation because it combines advanced technology with a powerful rejuvenating agent. Unlike traditional treatments like topical creams or surgical facelifts, microneedling RF delivers energy below the skin's surface to stimulate collagen production more effectively. The addition of PLLA, a biocompatible substance, further enhances skin volume and smoothness. This combination promises to rejuvenate skin with minimal downtime, offering a less invasive yet potent alternative to existing options.
What evidence suggests that this trial's treatments could be effective for facial rejuvenation?
Studies have shown that microneedling with radiofrequency (RF), one of the treatments in this trial, can noticeably improve skin appearance and texture, with benefits lasting for months. Research indicates that this technique tightens and refreshes the skin by boosting collagen production. In this trial, some participants will receive microneedling RF combined with a cream called poly-L-lactic acid (PLLA), another treatment arm. This combination is believed to enhance the treatment's effectiveness in firming loose skin and increasing skin thickness without causing fat loss. Early findings suggest that using both treatments together might be more effective for facial rejuvenation than microneedling RF alone. This new method likely works by creating tiny channels in the skin, allowing PLLA to penetrate and initiate a healing process.14678
Who Is on the Research Team?
Ying Chen, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for individuals seeking facial rejuvenation who can consent and follow the study plan. It's not for those with keloid scars, PLLA allergies, current aesthetic treatment trials, HIV+, pregnant/breastfeeding women, recent facial treatments/surgeries, skin infections/lesions in the area or using certain diabetes drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive microneedling RF treatment with or without topical PLLA
Follow-up
Participants are monitored for changes in satisfaction and perceived outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Microneedling Radiofrequency
- PLLA
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor